1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 01 JUNE 2015

Key Pharma News 01 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 38 pages

Industry Trend Analysis - Speedy Approvals Increasing Fast Track Designation Appeal
Industry Trend Analysis - J&J To Enhance Position In HCV
Industry Brief - SDP/Takeda To Terminate Agreement For Latuda In Europe
Industry Trend Analysis - Biologics Focus To Continue Driving In-House Biomanufacturing Investment
Industry Brief - AbbVie Completes Pharmacyclics Acquisition
Industry Trend Analysis - Biologics Will Front AstraZeneca's Oncology Reinvigoration
Industry Trend Analysis - Lundbeck's Revenue To Remain Stable In 2015
Industry Brief - UNC-Chapel Hill/GSK Enter Collaboration To Discover HIV Cure
Industry Brief - Pfizer Acquires Minority Interest In AM-Pharma; Secures Option To Acquire Company
Industry Trend Analysis - Adding To Oncology Portfolio Will Secure Baxalta's Future Growth
Industry Trend Analysis - Teva's Generic Sales Will Remain Dominant Over Actavis In FY15
Industry Trend Analysis - Par Acquisition Will Boost Endo's Generics Identity
Industry Trend Analysis - J&J Will Rely On An Expanded Immunology Portfolio To Offset Growing Remicade Competition
Industry Trend Analysis - Local Oncology Presence Continues To Grow
Industry Trend Analysis - Return To Australia Will Boost Strides' Regulated Markets Revenues
Industry Trend Analysis - Merck To Create Impact In HCV Despite Late Entry
Industry Brief - EMA Validates Gilead's MAA For F/TAF-Based HIV Regimen
Industry Brief - Imbruvica Gains CHMP Positive Opinion In WM
Industry Brief - Cymbalta Approved In Japan For Pain Associated With Fibromyalgia
Industry Brief - Opdivo Gains CHMP Positive Opinion For Previously-Treated Advanced Squamous NSCLC
Industry Brief - Eisai Launches Lenvima In Japan For Unresectable TC
Industry Trend Analysis - J&J's Invega Franchise Will Remain A Blockbuster
Industry Trend Analysis - Zykadia Will Not Surpass Xalkori Without First-Line Approval
Industry Brief - Actavis Launches Namzaric
Industry Brief - FDA Advisory Panel Recommends Approval Of Orkambi
Industry Brief - Zambon Launches Xadago For Mid- To Late-Stage PD In Germany
Industry Trend Analysis - Latest US Biosimilar Legislation Provides A Model That Will Resolve Key Concern
Industry Trend Analysis - Efficacy Will Fuel LABA/LAMA Market Expansion
Industry Trend Analysis - Aurobindo's Dolutegravir ANDA Will Ultimately Benefit ViiV And Improve Access
Industry Brief - Cempra Reports Phase III Data For Oral Solithromycin In CABP
Industry Trend Analysis - Gilead Will Be Seeking Further Candidates Following HBV Vaccine Failure
Industry Brief - FDA Amends Breakthrough Therapy Designation For BMS' Daclatasvir-Based HCV Regimen
Industry Trend Analysis - Orexigen's Shares Slump But Contrave Sales Will Not Follow Suit
Industry Trend Analysis - Roche Set To Undertake Big Oncology Filings
Industry Trend Analysis - Manufacturing Process Will Have Significant Impact On CAR-T Therapy Price
Industry Trend Analysis - Aurora Kinase Inhibitors Face Bleak Future
Industry Trend Analysis - T-VEC Set To Become First Western Viral Immunotherapy

Table Of Contents

Key Pharma News 01 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.